26 results
8-K
EX-10.1
BTAX
Biostax Corp.
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
damage caused by alcohol abuse, hepatitis, cirrhosis, bacterial infection or environment toxins
India
3435/DELP/2004
IN240229
(License out)
官網沒有從 … or environment toxins
Japan
JP5438250
(License out)
官網資訊權利者為タイワンジェ
ファーマシュティカルズ
カンパニー リミテッド
(2022/4/20瀏覽)
Liver and kidney damages associated
8-K
7pu k2fxdjnlirgivpz
19 Feb 20
Immune Therapeutics, Inc. Appoints New Independent Director
4:31pm
S-1
yyfkj4grk25q8ra094
14 Oct 16
IPO registration
12:00am
DRS/A
vz2bxpehicgxtqwg7t82
14 Oct 16
Draft registration statement (amended)
12:00am
10-K
a701cn
31 Mar 14
Annual report
12:00am
10-12G/A
qcn0v 12w9vnk
7 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
ei5j343
23 Jan 14
Registration of securities (amended)
12:00am
10-12G/A
3itnvx od
21 Nov 13
Registration of securities (amended)
12:00am